Novistra Capital
Top Layer Top Layer
healthcare-2560x515

Healthcare

Linkedin Icon X Icon

Novistra Capital advises Percos, a leading dermatology focused pharmaceutical company, for the sale of its Vedaderm brand to Cipla

Novistra Capital, a New York based global financial services firm, announced today that Percos India Pvt. Ltd., one of India’s leading dermatology focused skin-care company, has sold its Vedaderm brand of cosmeceutical and chemical peel products to Cipla, India’s third largest drug-maker.

Percos India, founded by one of India’s top Dermatologists, Dr. V. K. Upadhyaya, is one of India’s leading dermatology focused skin care company with its head office in New Delhi, India. Percos, over the years, has developed a strong brand in the doctor-prescribed and medical aesthetics dermatology market by developing a strong portfolio of products for treatment of skin disorders such as psoriasis, acne, wrinkles, aging of the skin, hyper-pigmentation and more.

Cipla is India’s third largest drug-maker that is engaged in the business of manufacturing, processing, promotion, marketing, sale and distribution of medicinal and pharmaceutical preparations of various kinds and nature for varying ailments and disorders. The Company is based out of Mumbai, India.

healthcare-2560x515

Deal Team

Ripun-1-2560x2560

Ripun Jai Mehta

Managing Partner

Subscribe to Novistra Insights

Latest news and insights delivered directly to your inbox.

By subscribing you agree to with our Privacy Policy.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

bg-2560x1977

From the Newsroom

View All
Rectangle-426-1-scaled-2560x718

Ideas are better
explored together

To read more, download report

Latest news and insights delivered directly to your inbox.

Report is delivered in your inbox.

By subscribing you agree to with our Privacy Policy.